CCR5 antagonists: bicyclic isoxazolidines as conformationally constrained N-1-substituted pyrrolidines
- 6 February 2002
- journal article
- research article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry Letters
- Vol. 12 (4), 677-679
- https://doi.org/10.1016/s0960-894x(01)00835-6
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Combinatorial synthesis of CCR5 antagonistsBioorganic & Medicinal Chemistry Letters, 2001
- Discovery of 4-[(Z)-(4-Bromophenyl)- (ethoxyimino)methyl]-1‘-[(2,4-dimethyl-3- pyridinyl)carbonyl]-4‘-methyl-1,4‘- bipiperidine N-Oxide (SCH 351125): An Orally Bioavailable Human CCR5 Antagonist for the Treatment of HIV InfectionJournal of Medicinal Chemistry, 2001
- 1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists. Part 2: lead optimization affording selective, orally bioavailable compounds with potent Anti-HIV activityBioorganic & Medicinal Chemistry Letters, 2001
- 1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists. Part 1: discovery of the pyrrolidine scaffold and determination of its stereochemical requirementsBioorganic & Medicinal Chemistry Letters, 2001
- A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activityProceedings of the National Academy of Sciences, 1999
- CHEMOKINE RECEPTORS AS HIV-1 CORECEPTORS: Roles in Viral Entry, Tropism, and DiseaseAnnual Review of Immunology, 1999
- A Conserved HIV gp120 Glycoprotein Structure Involved in Chemokine Receptor BindingScience, 1998
- Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibodyNature, 1998
- Asymmetric 1,3-Dipolar Cycloaddition ReactionsChemical Reviews, 1998
- Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor geneNature, 1996